REGENERON PHARMACEUTICALS, INC. Repayments of Long-Term Debt
REGENERON PHARMACEUTICALS, INC. (REGN) reported Repayments of Long-Term Debt of $12.86 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2017-05-04
- REGENERON PHARMACEUTICALS, INC. repayments of long-term debt for the quarter ending 2017-03-31 was $12.86M, a 2050.67% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. repayments of long-term debt for the quarter ending 2016-03-31 was $598.00K.
| Period end | Repayments of Long-term Debt 3 month |
|---|---|
| 2017-03-31 | $12.86M 10-Q · filed 2017-05-04 |
| 2016-03-31 | $598.00K 10-Q · filed 2017-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |